Bharat Biotech readying Tuberculosis, Cholera vaccines
Suchitra Ella says BBIL has stopped production of the COVID-19 vaccines as done by other manufacturers worldwide
Suchitra Ella says BBIL has stopped production of the COVID-19 vaccines as done by other manufacturers worldwide
The innovation segment is dominated by pharma services (CDMO, CRO, pharma IT) and health-tech with vaccines and biotech, and med-tech emerging as green shoots
Wockhardt and Serum Life Sciences UK will make a new sterile fill and finish facility in Wrexham, North Wales in the UK.
API, diagnostics, New Chemical Entity — Covid has thrown up new opportunities, and domestic pharma biggies are charging in with renewed focus.
Resurgence of interest and new technologies bring a huge opportunity for the vaccine development field, says Biocon CMD Kiran Mazumdar-Shaw.